Clinical Benefit—not Billing Margin—Drives Oncologists’ Treatment Choices in Medicare Cohort
Highlights
– In a retrospective, population-based Medicare cohort (2015–2020), treatment selection across 12 cancer indications was associated with higher clinical benefit (NCCN Evidence Blocks) but not with provider billing margin.
– Provider billing margin per course varied widely (up to $12,692) but a $100 increase in margin did not raise the odds of a treatment being chosen (OR 0.97, 95% CI 0.91–1.03).
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.